2025-03-04 - Analysis Report
## Procter & Gamble Co (PG) Stock Analysis

**0) Introduction:** Procter & Gamble Co (PG) is a multinational consumer goods company producing and marketing various household and personal care products.  This report analyzes PG's performance based on provided data.


**1) Performance Comparison with S&P 500 (VOO):**

PG's cumulative return is 86.24%, while the S&P 500's is 116.17%.  The difference is -29.9%, indicating PG underperformed the S&P 500.  The relative underperformance, considering the historical range of -47.5% to 38.8%, is at the 20.4th percentile. This suggests PG's underperformance is not extreme compared to its historical fluctuations relative to the S&P 500.

Alpha and Beta analysis reveals varying performance over different periods. While CAGR (Compound Annual Growth Rate) fluctuates, Alpha (a measure of excess return compared to the market) is mostly positive but modest, suggesting the stock outperformed the market in some periods but not consistently.  Beta (a measure of volatility relative to the market) generally stays within a reasonable range.  Market capitalization (Cap(B)) shows consistent growth throughout the analyzed years.



**2) Recent Price Movement:**

* **Closing Price:** 173.84
* **Last Market Price:** 175.22 (a slight increase of 0.79)
* **5-day Moving Average:** 172.06
* **20-day Moving Average:** 168.94
* **60-day Moving Average:** 167.30

The price is currently above all three moving averages, suggesting a short-term upward trend.  The recent price increase of 0.79 might not be considered a "sharp" increase considering the typical volatility of the stock.


**3) Technical Indicators and Expected Return:**

* **RSI:** 61.42 (slightly above neutral, indicating neither overbought nor oversold conditions)
* **PPO:** 0.32 (positive, suggesting bullish momentum)
* **20-day Relative Divergence:** +7.0 (positive, short-term upward trend)
* **Expected Return (vs. S&P 500):** -11.3% (This suggests a projected underperformance relative to the S&P 500 over the long term (2+ years)  if investing with a long-term horizon)


**4) Recent Earnings Analysis:**

| Date       | EPS   | Revenue      |
|------------|-------|-------------|
| 2025-01-22 | 1.94  | $21.88B      |
| 2024-10-18 | 1.65  | $21.74B      |
| 2024-04-19 | 1.56  | $20.20B      |
| 2024-01-23 | 1.44  | $21.44B      |
| 2025-01-22 | 1.44  | $21.44B      |


There seems to be a data duplication for 2025-01-22.  Excluding this duplication, earnings show some volatility. Revenue remains relatively stable, while EPS fluctuates.  A more in-depth analysis would require additional data points and industry comparisons.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue     | Profit Margin |
|-------------|-------------|---------------|
| 2024-12-31  | $21.88B    | 52.39%        |
| 2024-09-30  | $21.74B    | 52.06%        |
| 2024-06-30  | $20.53B    | 49.60%        |
| 2024-03-31  | $20.20B    | 51.20%        |
| 2023-12-31  | $21.44B    | 52.69%        |

Revenue is relatively consistent, with a slight dip in Q2 2024. Profit margins are consistently high, indicating strong profitability.


**Capital and Profitability:**

| Quarter     | Equity      | ROE           |
|-------------|-------------|---------------|
| 2024-12-31  | $51.17B    | 9.05%         |
| 2024-09-30  | $51.84B    | 7.64%         |
| 2024-06-30  | $50.29B    | 6.24%         |
| 2024-03-31  | $50.06B    | 7.50%         |
| 2023-12-31  | $48.53B    | 7.15%         |

Equity shows some fluctuation, and ROE (Return on Equity) is generally good but not consistently high.


**6) Overall Conclusion:**

PG shows strong profitability and relatively stable revenue. However, its performance has lagged behind the S&P 500 recently. While technical indicators suggest a short-term upward trend, the long-term expected return is projected to underperform the S&P 500.  Further analysis, considering macroeconomic factors and competitive landscape, is recommended before making any investment decisions. The duplicated data in the earnings report should be investigated and corrected.
